Paper · 39609906
Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.
Bakhshimoghaddam F and 11 others. BMC Nutr, 2024. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies. Papers, record 39609906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39609906
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,436,528 | Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease. | Int J Food Sci Nutr | 2016 | https://conductscience.org/library/papers/27436528 | PubMed |
| 2 | 21,392,646 | The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | J Am Coll Cardiol | 2011 | https://conductscience.org/library/papers/21392646 | PubMed |
| 3 | 32,706,078 | Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32706078 | PubMed |
| 4 | 31,162,803 | Association between nut consumption and non-alcoholic fatty liver disease in adults. | Liver Int | 2019 | https://conductscience.org/library/papers/31162803 | PubMed |
| 5 | 26,503,843 | The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. | Liver Int | 2016 | https://conductscience.org/library/papers/26503843 | PubMed |
| 6 | 30,700,946 | Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/30700946 | PubMed |
| 7 | 33,672,073 | Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients. | Nutrients | 2021 | https://conductscience.org/library/papers/33672073 | PubMed |
| 8 | 30,674,308 | The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study. | BMC Med | 2019 | https://conductscience.org/library/papers/30674308 | PubMed |
| 9 | 36,096,063 | The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review. | Clin Nutr | 2022 | https://conductscience.org/library/papers/36096063 | PubMed |
| 10 | 33,234,342 | Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study. | Clin Nutr | 2021 | https://conductscience.org/library/papers/33234342 | PubMed |
1 to 10 of 81
See all 81 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,643,230 | Dietary patterns and their relationship with hepatobiliary health in patients with nonalcoholic fatty liver disease and gallstone disease. | Front Nutr | 2026 | https://conductscience.org/library/papers/42643230 | PubMed |
| 42,514,385 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants. | Nutrients | 2026 | https://conductscience.org/library/papers/42514385 | PubMed |
| 42,429,613 | Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42429613 | PubMed |
| 42,088,286 | Mixture design-based optimization of bioactivities in steamed grain and legume blends. | Food Chem X | 2026 | https://conductscience.org/library/papers/42088286 | PubMed |
| 41,555,432 | Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/41555432 | PubMed |
| 40,244,373 | ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet. | Mol Divers | 2025 | https://conductscience.org/library/papers/40244373 | PubMed |
| 40,218,971 | Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD. | Nutrients | 2025 | https://conductscience.org/library/papers/40218971 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39609906
GET https://conductscience.org/api/papers/v1/39609906/references?page=2